Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
2017 ◽
Vol 18
(12)
◽
pp. 1590-1599
◽
Alice T Shaw
◽
Enriqueta Felip
◽
Todd M Bauer
◽
Benjamin Besse
◽
Alejandro Navarro
◽
...
2016 ◽
Vol 17
(4)
◽
pp. 452-463
◽
Dong-Wan Kim
◽
Ranee Mehra
◽
Daniel S W Tan
◽
Enriqueta Felip
◽
Laura Q M Chow
◽
...
2016 ◽
Vol 27
◽
pp. ix143
L. Zhang
◽
Y. Shi
◽
D.S.W. Tan
◽
B. Hu
◽
L. Xiaoqing
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. 9062-9062
◽
D. Ross Camidge
◽
Gregory Alan Otterson
◽
Jeffrey W. Clark
◽
Sai-Hong Ignatius Ou
◽
Jared Weiss
◽
...
2016 ◽
Vol 17
(7)
◽
pp. 883-895
◽
Scott J Antonia
◽
José A López-Martin
◽
Johanna Bendell
◽
Patrick A Ott
◽
Matthew Taylor
◽
...
2016 ◽
Vol 27
(suppl_9)
◽
L. Zhang
◽
Y. Shi
◽
D.S.W. Tan
◽
B. Hu
◽
L. Xiaoqing
◽
...
2011 ◽
Vol 6
(11)
◽
pp. 1915-1922
◽
Christopher G. Azzoli
◽
Jyoti D. Patel
◽
Lee M. Krug
◽
Vincent Miller
◽
Leonard James
◽
...
2012 ◽
Vol 23
◽
pp. ix424
◽
N. Yamamoto
◽
H. Murakami
◽
T. Takahashi
◽
H. Hayashi
◽
Y. Fujisaka
◽
...
2019 ◽
Vol 7
(4)
◽
pp. 347-357
◽
Natasha B Leighl
◽
Matthew D Hellmann
◽
Rina Hui
◽
Enric Carcereny
◽
Enriqueta Felip
◽
...
Justin F Gainor
◽
Giuseppe Curigliano
◽
Dong-Wan Kim
◽
Dae Ho Lee
◽
Benjamin Besse
◽
...
Close
Export Citation Format
Close
Share Document
Close